Initial data for the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9 expected in second quarter of 2025Dosing in the Heart-2 trial ...

LUND, Sweden, Jan. 7, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), today announced that management will attend the 43rd Annual J.P. Morgan Healthcare ...

Accelerating IMPT-314 in large B-cell lymphoma; remain on track to initiate pivotal trial in the 3rd line+ setting in 2025 and expect to initiate ...

today announced that the Company will present its strategic outlook for 2025 at the 43 rd Annual J.P. Morgan Healthcare ...

We recently compiled a list of the 10 Best Financial Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 ...

Silicom Ltd. , a leading provider of networking and data infrastructure solutions, today announced that an existing customer, a major US-based cyber security company, has expanded its business with ...

BioLineRx Ltd.  ("BioLineRx" or the "Company"), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it has entered into ...

CyberArk Software (NASDAQ:CYBR) was named the top stock for 2025 in the cybersecurity space by Needham Securities, amid ...

Latham landed on several of the biggest deals in the last half of December, while Paul Weiss and Debevoise steered a mega ...

Hansa Biopharma AB, "Hansa" or the "Company" (Nasdaq Stockholm: HNSA), today announced that management will attend the 43rd Annual J.P. Morgan Healthcare ...

28, 2017. (Mainichi) TOKYO (Kyodo) -- The government will compile a record 115.5 trillion yen ($734 billion) initial budget for fiscal 2025 as defense and social security spending continue to rise ...